FLT3 and acute myeloid leukemia: Compared with the general AML population, patients with FLT3 internal tandem duplication (ITD) mutations have a higher risk of relapse and a shorter overall survival, while the impact of FLT3 tyrosine kinase domain (TKD) mutations on outcomes is less clear [11].